CAMBRIDGE, Mass., June 4, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon...
ProBio and GCP ClinPlus today announced a strategic collaboration designed to accelerate Investigator-Initiated Trials (IITs) in China and provide integrated, end-to-end clinical and development...
Is Increased Use of PGT-A Always Better? Experts Call for Evidence-Based Use of Mosaic EmbryosChoosing the Right PGT-A Platform: NUWA Fertility and Global Experts Unite...
Clinical Stage Biotechnology Company Uses Patient Immune System to "Seek and Destroy" Cancer and Metastasis
SAN DIEGO, Aug. 1, 2025 /PRNewswire/ -- Res Nova Biologics,...
Innovative modular design will accelerate construction and manufacturing timelines, enabling rapid adaptation of manufacturing capacities across diverse product formats.Finished building will be one of...
ALTRINCHAM, England, July 3, 2025 /PRNewswire/ -- A new study is the first to examine the application of behavioural science in getting underused therapies...
IRVINE, Calif., June 18, 2025 /PRNewswire/ -- As research and diagnostic companies grapple with rising prices and persistent backorders from offshore suppliers, Zymo Research is...
SHELTON, Conn., June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the...
SHELTON, Conn., June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the...
LUND, Sweden, June 11, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (NASDAQ Stockholm: HNSA), today announced that Hansa's CEO Renée Aguiar-Lucander will speak at the...
DELRAY BEACH, Fla., June 10, 2025 /PRNewswire/ -- The global Exosome Research Market, valued at US$189.4 million in 2024 stood at US$214.4 million in 2025...
SAN DIEGO, June 9, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the appointment of Lewis Choi as Chief Information Officer, effective June...
Series A funding to advance MOS118 through Phase 2 clinical trials
Biotech veteran David Weber appointed CEO to drive clinical development
Obstructive sleep apnea affects nearly...